165 related articles for article (PubMed ID: 32631586)
1. A randomized trial on the effect of oral combined estradiol and drospirenone on glucose and insulin metabolism in healthy menopausal women with a normal oral glucose tolerance test.
Depypere H; Dierickx A; Vandevelde F; Stanczyk F; Ottoy L; Delanghe J; Lapauw B
Maturitas; 2020 Aug; 138():36-41. PubMed ID: 32631586
[TBL] [Abstract][Full Text] [Related]
2. Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
Paoletti AM; Cagnacci A; Di Carlo C; Orrù MM; Neri M; D'Alterio MN; Melis GB
Gynecol Endocrinol; 2015 May; 31(5):384-7. PubMed ID: 25703254
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
[TBL] [Abstract][Full Text] [Related]
4. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
Vitale C; Mammi C; Gambacciani M; Russo N; Spoletini I; Fini M; Volterrani M; Rosano GMC
Int J Cardiol; 2017 Jan; 227():217-221. PubMed ID: 27843051
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome.
Rizzo MR; Leo S; De Franciscis P; Colacurci N; Paolisso G
Age (Dordr); 2014 Feb; 36(1):265-74. PubMed ID: 23832170
[TBL] [Abstract][Full Text] [Related]
6. 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.
Gerlinger C; Gude K; Schmelter T; Schaefers M; Endrikat J
Climacteric; 2015; 18(4):512-7. PubMed ID: 26000627
[TBL] [Abstract][Full Text] [Related]
7. Clinical responses to the combination of estradiol and drospirenone in symptomatic postmenopausal Thai women.
Chaikittisilpa S; Angsuwathana S; Chaovisitsaree S; Jirapinyo M; Wilawan K; Panyakhamlerd K; Jaisamrarn U; Techatraisak K; Morakote N; Suchartwatnachai C; Kongmephol W; Taechakraichana N
J Med Assoc Thai; 2011 Sep; 94(9):1019-25. PubMed ID: 21970189
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL
Menopause; 2005; 12(6):716-27. PubMed ID: 16278615
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.
Warming L; Ravn P; Nielsen T; Christiansen C
Climacteric; 2004 Mar; 7(1):103-11. PubMed ID: 15259289
[TBL] [Abstract][Full Text] [Related]
10. Effect of estradiol-drospirenone hormone treatment on myocardial perfusion reserve in postmenopausal women with angina pectoris.
Knuuti J; Kalliokoski R; Janatuinen T; Hannukainen J; Kalliokoski KK; Koskenvuo J; Lundt S
Am J Cardiol; 2007 Jun; 99(12):1648-52. PubMed ID: 17560868
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion.
Cucinelli F; Paparella P; Soranna L; Barini A; Cinque B; Mancuso S; Lanzone A
Eur J Endocrinol; 1999 Mar; 140(3):215-23. PubMed ID: 10216516
[TBL] [Abstract][Full Text] [Related]
12. Low-dose hormone therapy and carbohydrate metabolism.
Li C; Samsioe G; Borgfeldt C; Bendahl PO; Wilawan K; Aberg A
Fertil Steril; 2003 Mar; 79(3):550-5. PubMed ID: 12620438
[TBL] [Abstract][Full Text] [Related]
13. The effects of 17β-estradiol plus drospirenone on anthropometric and biochemical measures of adiposity in menopausal women.
Karakus M; Gelisgen R; Topcuoglu A; Guralp O; Topcuoglu D; Simsek G; Uludag S; Uzun H
Arch Gynecol Obstet; 2012 Nov; 286(5):1233-9. PubMed ID: 22791413
[TBL] [Abstract][Full Text] [Related]
14. Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril.
Preston RA; Alonso A; Panzitta D; Zhang P; Karara AH
Am J Hypertens; 2002 Sep; 15(9):816-22. PubMed ID: 12219878
[TBL] [Abstract][Full Text] [Related]
15. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
Oelkers WH
Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
[TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review.
Carranza-Lira S
Clin Interv Aging; 2009; 4():59-62. PubMed ID: 19503766
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
White WB; Pitt B; Preston RA; Hanes V
Circulation; 2005 Sep; 112(13):1979-84. PubMed ID: 16186434
[TBL] [Abstract][Full Text] [Related]
18. Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens.
Schürmann R; Holler T; Benda N
Climacteric; 2004 Jun; 7(2):189-96. PubMed ID: 15497908
[TBL] [Abstract][Full Text] [Related]
19. Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study.
Morin-Papunen LC; Vauhkonen I; Ruokonen A; Tapanainen JS; Raudaskoski T
Eur J Endocrinol; 2004 May; 150(5):705-14. PubMed ID: 15132728
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
